Evidence map›Paper›PMID 35056138›Full record

ReviewPharmaceuticals (Basel, Switzerland)2022

Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: Modulation of TRPM4.

Zsigmond Máté Kovács, Csaba Dienes, Tamás Hézső, János Almássy, János Magyar, Tamás Bányász, Péter P Nánási, Balázs Horváth, Norbert Szentandrássy

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zsigmond Máté KovácsDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Csaba DienesDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Tamás HézsőDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
János AlmássyDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
János MagyarDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Tamás BányászDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Péter P NánásiDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Balázs HorváthDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0003-2562-8446
Norbert SzentandrássyDepartment of Physiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
University of Debrecen · HU

Funding

European Union and the European Regional Development Fund GINOP-2.3.2-15-2016-00040, EFOP-3.6.2-16-2017-00006, EFOP-3.6.3-VEKOP-16-2017-00009National Research Development and Innovation Fund ÚNKP-20-2National Research Development and Innovation Office NKFIH-K115397, NKFIH-K138090, NKFIH-FK128116Thematic Excellence Program of the Ministry for Innovation and Technology in Hungary TKP-2020-NKA-04
6 · The paper itself

Abstract

Transient receptor potential melastatin 4 is a unique member of the TRPM protein family and, similarly to TRPM5, is Ca

Indexed as

9-phenanthrolantibodyCBAflufenamic acidsiRNASUR1TRPM4TRPM4 activatorTRPM4 inhibitor

Identifiers

PMID35056138
PMCPMC8781449
OpenAlexW4205494015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.